Random: CANNABIS SCIENCE INC posts gains for the day

cannabis prescriptionCANNABIS SCIENCE INC (OTC: CBIS) increased 35.37%, on overall traded volume of 6.43 million shares for the day. The day high was at $0.20 and shares of CBIS closed the day at $0.20. Cannabis Science, Inc. engages in the research and development, production, and commercialization of phytocannabinoid based pharmaceutical products. Its cannabinoid pharmaceuticals targets various serious needs that include neuro-muscular disorders; neuropathic pain related to spinal cord injuries, as well as conditions, such as AIDS/HIV; chronic pain; respiratory inflammation related to both infections, such as influenza and to autoimmune diseases comprising asthma; cancer, including pain management, and control of cancer in conditions, such as pheochromocytoma; digestive illnesses consisting of gastroesophageal reflux disease, crohn’s disease, and irritable bowel syndrome; dermatological infections, such as flesh eating disease; and sleep disorders.